A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
Purpose
The purpose of this study is to characterize the distribution of lipoprotein(a) (Lp(a)) levels among participants with a history of ASCVD as defined by their medical history and is 2-fold: - Evaluate the distribution of Lp(a) value in the overall participants with documented history of ASCVD - Evaluate the distribution of Lp(a) value in participants with documented history of ASCVD by demographics and regions
Condition
- Atherosclerotic Cardiovascular Disease
Eligibility
- Eligible Ages
- Between 18 Years and 85 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Signed informed consent - History of ASCVD
Exclusion Criteria
- Participants known to be currently receiving investigational drug in a clinical study - Participants with a diagnosis of end-stage renal disease or requiring dialysis - Participants who have received lipoprotein apheresis to reduce Lp(a) within 3 months prior to enrollment
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Basic Science
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Other Participants with history of ASCVD |
Participants with history of ASCVD with known or unknown Lp(a) values. |
|
More Details
- Status
- Completed
- Sponsor
- Amgen